Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

NASDAQLPCN
YearTrailing 12-MonthsCalendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
PX14A6GNotice of exempt solicitation. Definitive materialMay 20, 2020Open Notice of exempt solicitation. Definitive material in HTML.Open Notice of exempt solicitation. Definitive material in DOC file.Open Notice of exempt solicitation. Definitive material in PDF file.Open Notice of exempt solicitation. Definitive material in XLS file.
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 28, 2020Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in HTML.Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in DOC file.Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in PDF file.Open Official notification to shareholders of matters to be brought to a vote ("Proxy") in XLS file.